Telbivudine 100 mg per 5 mL Oral Solution
RxNorm 894853
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 894853 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: telbivudine 100 mg per 5 mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Telbivudine 20 mg/ML Oral Solution
(Atom ID: 3048193)
FN
Full form of descriptor (FN):
Product containing precisely telbivudine 20 mg/1 mL conventional release oral solution (clinical drug)
(Atom ID: 11440779)
SY
Synonym (SY):
Telbivudine 100 mg per 5 mL Oral Solution
(Atom ID: 3059786)
PT
Designated preferred name (PT):
Telbivudine 20 mg/mL oral solution
(Atom ID: 11441424)
Patient Education
Telbivudine
Telbivudine is used for chronic (long term) hepatitis B infection (swelling of the liver caused by a virus) in people who may also show signs of liver damage. Telbivudine is in a class of medications called nucleoside analogues. It works by decreasing the amount of hepatitis B virus (HBV) in the body. Telbivudine does not cure hepatitis B and may not prevent complications of chronic hepatitis B, such as cirrhosis of the liver or liver cancer. Telbivudine does not prevent the spread of hepatitis B to other people through sexual contact, sharing needles, or contact with blood.
[Learn More]
* Please review the disclaimer below.